During the past decade, Ocean Allergy & Respiratory Research Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ocean Allergy & Respiratory Research Center" #1 collaborator was "Sanofi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ocean Allergy & Respiratory Research Center" are "Asthma" (3 trials) and "Perennial Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Ocean Allergy & Respiratory Research Center" in a lesser frequency.

Most popular intervention types in "Ocean Allergy & Respiratory Research Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Budesonide/Formoterol fumarate dihydrate" (1 trials), "DUPIXENT®" (1 trials), "Fluticasone" (1 trials) and "Omalizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ocean Allergy & Respiratory Research Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ocean Allergy & Respiratory Research Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ocean Allergy & Respiratory Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ocean Allergy & Respiratory Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".